ProfileGDS5822 / ILMN_1216122
TitleAnti-CTLA-4 immunotherapy effect on αSMA+ myofibroblast late-depleted pancreatic ductal adenocarcinoma model
OrganismMus musculus


control myofibroblast depletion untreated anti-CTLA4 antibody GSM1276599 GSM1276600 GSM1276601 GSM1276602 GSM1276603 GSM1276604 GSM1303940 GSM1303941 GSM1303942 90% 88% 91% 89% 90% 90% 91% 92% 94% sort by protocol sort by agent Gene Expression Profile
Graph caption help
SampleTitleValueRank
GSM1276599PDAC Late Ablation Control 1472.590
GSM1276600PDAC Late Ablation Control 2370.788
GSM1276601PDAC Late Ablation Control 3665.991
GSM1276602PDAC Late Ablation 1417.589
GSM1276603PDAC Late Ablation 2528.690
GSM1276604PDAC Late Ablation 3524.290
GSM1303940PDAC Late Ablation_anti-CTLA4 1538.191
GSM1303941PDAC Late Ablation_anti-CTLA4 2808.192
GSM1303942PDAC Late Ablation_anti-CTLA4 31173.294